Skip to content
Return home
Contact Us 617.823.3217
  • Our Team
    • About Us
    • Jeffrey A. Newman
    • Rea Kasemi
    • The Analyst Team
  • Practice Areas
    • Healthcare and Medicare Fraud
      • Healthcare and Medicare Fraud Overview
      • Upcoding and Provider Billing Fraud
      • Urgent Care Fraud
      • Pharmaceutical and Medical Device Kickbacks
      • Pharmaceutical Price Reporting Fraud
      • Laboratory Kickbacks and Unnecessary Testing
      • Defective and Unapproved Medical Devices
      • Nursing Home Rehabilitation Therapy Fraud
      • Hospital Fraud
      • Pharmacy Fraud
      • Electronic Health Records Fraud
      • Physician Whistleblower Attorneys
    • Customs and Tariff Fraud
      • Tariff Fraud
    • Securities and Financial Fraud
      • Securities and Financial Fraud Overview
      • Financial Statement and Disclosure Fraud
      • Foreign Bribery and Corruption
      • Front Running
      • Insider Trading
    • Export Control Violations
  • Representative Cases
  • In The News
  • Resources
    • Whistleblower Help CenterĀ®
    • Whistleblower Laws
      • Federal Whistleblower Laws
      • State Whistleblower Laws
    • The Enforcement Record
  • Blog
  • Contact

Category: Pharmaceutical

Return home Pharmaceutical Page 25

Category: Pharmaceutical

SUPREME COURT STRIKES DOWN BAN ON DATA-MINING PHARMACY COLLECTED INFORMATION

Posted on June 23, 2011
The United States Supreme Court has issued a decision which strikes down a Vermont law banning the practice of data mining information collected by pharmacies including the name of the prescribing physician drug dosage and quantity of the medication and the patients age and gender, which in turn is sold to pharmaceutical companies. Data-mining...
Continue reading…

GOOGLE CLOSE TO SETTLING FEDERAL INQUIRY OVER ADS FOR UNLICENSED PHARMACEUTICALS

Posted on May 13, 2011
Google disclosed this week that it had reserved $500 million to resolve a U.S Justice Department investigation into its ads from companies selling unlicensed pharmaceuticals. Google, Microsoft and Yahoo have altered their policies in order to filter out ads that hawk prescription meds many from Canadian companies but where the drugs are manufactured in...
Continue reading…

Johnson and Johnson Earmarks Funds To Settle Risperdal Whistleblower Case

Posted on May 11, 2011
Johnson & Johnson has segregated moneys for a possible settlement with the U.S. government alleging violations of the Food, Drug and Cosmetic Act and the False Claims Act. J&J apparently marketed Risperdal for off label, non approved uses. Three former salespeople filed a whistleblower suit which said that J&J promoted Risperdal for conditions beyond...
Continue reading…

BIG PHARMA COMPANIES UNDER INVESTIGATION IN FOREIGN BRIBES SCANDAL

Posted on May 2, 2011
Several pharmaceutical companies including Merck, Medtronic, Zimmer and Astra Zeneca are reportedly under investigations for paying foreign bribes in violation of The Foreign Corrupt Practices Act (FCPA). Eli Lilly this week discloed that it is in discussions with the SEC to try to resolve an investigation as to the compliance by Polish subsidiaries of...
Continue reading…

Johnson & Johnson to Pay $70 million to Settle Foreign Bribes Charges

Posted on April 8, 2011
Johnson & Johnson agreed Friday to pay $70 million to settle charges that it bribed doctors in state run hospitals overseas to prescribe its drugs. The Government claims that J&J bribed docs in Europe and paid kickbacks in Iraq to get business, in violation of the Foreign Corrupt Practices Act. The company used...
Continue reading…

Johnson and Johnson Omnicare Kickback Whistleblower Suit To Continue Judge Says

Posted on February 28, 2011
A lawsuit filed against Johnson & Johnson by a whistleblower and the U.S. Department of Justice, alleging the company paid kickbacks to influence sales of its drugs will continue, says Federal Judge Richard Stearns. The company is alleged to have paid its kickbacks to Omnicare Inc. the largest U.S, pharmacy for nursing home patients,...
Continue reading…

DOJ : Several Admit Guilt In Biotech Insider Trading Scam

Posted on February 16, 2011
A Sequenom Inc. patent agent and his brother have pleaded guilty to conspiring to trade stock options of the maker of a genetic analysis product using inside information says the Department of Justice. According to court documents, the patent agent Aaron Scalia of San Diego and his brother Stephen of Baltimore used the private...
Continue reading…

Massachusetts Seeks $250 Million From Warrick Pharma–Schering-Plough Acquisition

Posted on January 24, 2011
The Commonwealth of Massachusetts has filed a strident Memo of Law in support of a $250 million fine against Warrick Pharmaceuticals/Schering Plough for pricing fraud on Proventil. A federal jury found against the company recently. Part of the claim was filed under The Massachusetts False Claims Act for claims caused to be presented to...
Continue reading…

Cobaltism Dangers to Patients With Metal On Metal Hip Implants

Posted on January 21, 2011
Depuy Orthopaedics Inc., a division of Johnson & Johnson recalled its metal on metal (MoM) Articular Surface Replacement (ASR) in August of this year due to a greater than 12 percent failure rate during the first five years of implantation. DePuy estimates that 93,000 ASR hips have been implanted and it recommends that ASR...
Continue reading…

Johnson & Johnson Sued by State Over Phantom Motrin Recall

Posted on January 13, 2011
The state of Oregon is suing Johnson & Johnson for hiring people to buy Motrin pain releiver off the shelves so that it would not have to issue a formal recall or tell consumers there was a problem with the drug. Oregon's Attorney General John Kroger says that the phantom recall placed the public...
Continue reading…

Posts navigation

Older posts
Newer posts
Contact Us Online
Categories
  • #
  • #AUDITING FRAUD
  • #autosafety
  • #DNAtesting
  • #healthcarefraud
  • #Kickbacks
  • #veterans services billing
  • $15 Mill whistleblower reward
  • Accounting fraud
  • AI
  • AI communications
  • AI profits
  • anti money laundering whistleblowers
  • bITCOIN
  • Blogs by Jeff Newman Law
  • Blogs by Jeffrey Newman
  • Bribes
  • Bribes in China
  • China
  • Class Actions
  • Commodity Future Trading Commission
  • Consumer Protection
  • Credit Card Fraud
  • Cryptocurrency
  • Cryptosecurity
  • customs fraud
  • Data Breach
  • Defense Contractor Fraud
  • Department Of Justice
  • destroying records
  • Diseases
  • E-Cigarettes
  • Environmental Protection
  • Export violations
  • False Claims Act
  • FCPA
  • FDA
  • financial fraud
  • foreign bribes
  • Foreign Fraud
  • Fraud
  • fugitive
  • Grant Fraud
  • Healthcare Fraud
  • Hedge fund losses
  • illegal frontrunning
  • Insider Trading
  • Iran finance
  • IRS Whistleblower
  • Law Firm News
  • Market Manipulation
  • Medicaid Fraud
  • Medicare Fraud
  • Mental Health Fraud
  • Motor Vehicle Safety Whistleblower Act
  • News
  • Pharmaceutical
  • Pharmacist fraud
  • PharmacyMedicarefraud
  • Ponzi Schemes
  • PPP loan fraud
  • Qui Tam
  • Radiationleakssealevelrise
  • ratings agencies fruad
  • Retaliation
  • rottedyellowfintuna
  • Sanctions Violations
  • SEC Whistleblower
  • Securities and Exchange Commission Investigations
  • Semconductors
  • Sexual Harassment
  • Starlink
  • Tariff Evasion
  • Tariff fraud
  • tax evasion
  • Tax evasion bank founder
  • Tax evasion Russian Bank founder
  • Tax Fraud
  • Trading firm layering jury verdict
  • Uncategorized
  • University marketing fraud
  • Visa Fraud
  • WellsFargoSettlement
  • whistleblower
  • Whistleblower Cases
  • Whistleblower Laws
    • Iran's finances
  • Whistleblower rights
  • whistleblowers
  • Whistleblowers rights
  • Wrongful Death
Our Office
75 State Street, Suite 100
Boston, MA 02109
Contact Us
Jeff Newman Law
75 State Street, Suite 100
Boston, MA 02109
Mailing Address
1 Story Terrace
Marblehead, MA 01945
Phone:
Call our office 617.823.3217
Representative
Cases
All Representative Cases United States ex rel. Halpin and Fahey v. RehabCare Group, Inc. ($125 Million) United States ex rel. Bliss v. Biocompatibles, Inc., and Angiodynamics, Inc. ($48.5 million)
Practice Areas
Healthcare and Medicare Fraud Customs and Tariff Fraud Procurement Fraud Securities and Financial Fraud Grant Fraud
Whistleblower
Resources
Do I have a viable case? The False Claims Act Whistleblower Protections
Call Menu Contact
Call Our Firm
Boston Office
Call our office 617.823.3217
Mailing Address
Call our office

© 2026 Jeff Newman Law | P: 617.823.3217
Attorney Advertising | Disclaimer / Privacy Policy | Website Development by Omnizant - View site in new window

Website developed in accordance with Web Content Accessibility Guidelines 2.1.
If you encounter any issues while using this site, please contact us: 617.823.3217
Return home
Call our office 617.823.3217
  • Our Team
    • About Us
    • Jeffrey A. Newman
    • Rea Kasemi
    • The Analyst Team
  • Practice Areas
    • Healthcare and Medicare Fraud
      • Healthcare and Medicare Fraud Overview
      • Upcoding and Provider Billing Fraud
      • Urgent Care Fraud
      • Pharmaceutical and Medical Device Kickbacks
      • Pharmaceutical Price Reporting Fraud
      • Laboratory Kickbacks and Unnecessary Testing
      • Defective and Unapproved Medical Devices
      • Nursing Home Rehabilitation Therapy Fraud
      • Hospital Fraud
      • Pharmacy Fraud
      • Electronic Health Records Fraud
      • Physician Whistleblower Attorneys
    • Customs and Tariff Fraud
      • Tariff Fraud
    • Securities and Financial Fraud
      • Securities and Financial Fraud Overview
      • Financial Statement and Disclosure Fraud
      • Foreign Bribery and Corruption
      • Front Running
      • Insider Trading
    • Export Control Violations
  • Representative Cases
  • In The News
  • Resources
    • Whistleblower Help CenterĀ®
    • Whistleblower Laws
      • Federal Whistleblower Laws
      • State Whistleblower Laws
    • The Enforcement Record
  • Blog
  • Contact
Close Menu
  • Our Team
    • About Us
    • Jeffrey A. Newman
    • Rea Kasemi
    • The Analyst Team
  • Practice Areas
    • Healthcare and Medicare Fraud
      • Healthcare and Medicare Fraud Overview
      • Upcoding and Provider Billing Fraud
      • Urgent Care Fraud
      • Pharmaceutical and Medical Device Kickbacks
      • Pharmaceutical Price Reporting Fraud
      • Laboratory Kickbacks and Unnecessary Testing
      • Defective and Unapproved Medical Devices
      • Nursing Home Rehabilitation Therapy Fraud
      • Hospital Fraud
      • Pharmacy Fraud
      • Electronic Health Records Fraud
      • Physician Whistleblower Attorneys
    • Customs and Tariff Fraud
      • Tariff Fraud
    • Securities and Financial Fraud
      • Securities and Financial Fraud Overview
      • Financial Statement and Disclosure Fraud
      • Foreign Bribery and Corruption
      • Front Running
      • Insider Trading
    • Export Control Violations
  • Representative Cases
  • In The News
  • Resources
    • Whistleblower Help CenterĀ®
    • Whistleblower Laws
      • Federal Whistleblower Laws
      • State Whistleblower Laws
    • The Enforcement Record
  • Blog
  • Contact